Menu

Image of the Day: Moth Resurrection

Entomologists have rediscovered a species of moth that was considered lost for 130 years. 

Dec 18, 2017
The Scientist Staff, The Scientist Staff

The bee-mimicking moth Heterosphecia tawonoidesMARTA SKOWRON VOLPONIAfter not finding a single specimen for 130 years, the oriental blue clearwing moth Heterosphecia tawonoides was re-discovered by entomologists in the jungles of Malaysia. The species was known only from a damaged museum specimen that had been collected in 1887. It not only looks like a bee, it also behaves like a bee in real life, the scientists found. 

M.A.S. Volponi & P. Volponi, "A 130-year-old specimen brought back to life: A lost species of bee-mimicking clearwing moth, Heterosphecia tawonoides (Lepidoptera: Sesiidae: Osminiini), rediscovered in peninsular Malaysia's primary rainforest," Trop Conserv Sci, doi:0.1177/1940082917739774, 2017. 

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
The National Institute Of Allergy And Infectious Disease recently awarded BellBrook Labs a $300,000 Small Business Innovative Research (SBIR) grant to develop novel inhibitors for the target cyclic GAMP Synthase (cGAS). The grant will be used to accelerate the discovery of new treatments for autoimmune diseases by targeting the cGAS-STING pathway.